Taking medical technology ventures to market worldwide
If the UK leaves the European Union without a Brexit deal, certain products placed on the UK market will be required to use the new UK product marking, the UKCA (UK Conformity Assessed) mark. The UKCA marking will apply to most goods currently subject to CE marking. CE marking will still be required for products being sold into the EU. Furthermore, all manufacturers based outside of the UK will require a “responsible person“ based in the UK.
Guidance can be found on the UK government website
Brexit/UKCA Marking Webinars - 5th November 2020; 3rd December 2020; and 10th December, 14.00 to 14.30
Psephos Biomedica works with clients from around the world to bring medical technologies to market.
We are a highly focused, experienced team that takes on a limited number of clients thus ensuring they get the best of us.